Varaico: Literature-Extracted Genetic Variants

Gene:TP53
Variant:p.M1L
Back to variants list

TP53

NM_000546.6:p.M1L

Associated Papers

Quantitative functional profiling of ERCC2 mutations deciphers cisplatin sensitivity in bladder cancer.

Börcsök J et al.

The Journal of Clinical Investigation, 2025

40829180 (PubMed )
Supplement: jci-135-186688-s236.xlsx › SFigure5E-G

Genetics of Darier's Disease: New Insights into Pathogenic Mechanisms.

Moschella B et al.

Genes, 2025

Performance and considerations in the use of diagnostic mutation panels for clonality testing in non-small-cell lung carcinoma.

Janssen J et al.

Esmo Open, 2025

40373350 (PubMed )
Supplement: mmc4.xlsx › 4c_Correctly_classified

Selective metabolic regulations by p53 mutant variants in pancreatic cancer.

Caporali S et al.

Journal of Experimental & Clinical Cancer Research : Cr, 2024

Genomic Features of Newly Diagnosed Large B-cell Lymphoma with or without Subsequent Disease Progression.

Landsburg DJ et al.

Cancer Research Communications, 2024

39392347 (PubMed )
Supplement: crc-24-0337_supplementary_data_suppsd.xlsx › Supplemental_Table_1

Variants in the first methionine of RAD51C are homologous recombination proficient due to an alternative start site.

Rein HL et al.

Dna Repair, 2024

Understanding the Genetic Landscape of Pancreatic Ductal Adenocarcinoma to Support Personalized Medicine: A Systematic Review.

Pantaleo A et al.

Cancers, 2023

38201484 (PubMed )
Supplement: cancers-16-00056-s001.zip › Table_S3_Proof_final_version.xlsx › PMS2

Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer.

Serebriiskii IG et al.

Npj Genomic Medicine, 2023

38001126 (PubMed )
Supplement: 41525_2023_384_MOESM1_ESM.xlsx › Table_S8

ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications.

El Jabbour T et al.

Journal of the National Cancer Institute, 2022

Alpha B-Crystallin in Muscle Disease Prevention: The Role of Physical Activity.

Dimauro I et al.

Molecules (basel, Switzerland), 2022

Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients.

Lieb V et al.

Cells, 2021

34831445 (PubMed )
Supplement: cells-10-03223-s001.zip › Suppl._Table_S1.xlsx › AR_variants

The Genomic Landscape of Lobular Breast Cancer.

McCart Reed AE et al.

Cancers, 2021

33919581 (PubMed )
Supplement: cancers-13-01950-s001.zip › cancers-1163927-supplementary_tables.xlsx › Table_S1_WES

BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas.

Colombino M et al.

Journal of Clinical Medicine, 2019

31581559 (PubMed )
Supplement: jcm-08-01577-s001.pdf

Mutational processes shape the landscape of TP53 mutations in human cancer.

Giacomelli AO et al.

Nature Genetics, 2018

30224644 (PubMed )
Supplement: NIHMS1501645-supplement-4.xlsx › Giacomelli_et_al_New_Supplement

The genomic landscape of malignant peripheral nerve sheath tumors: diverse drivers of Ras pathway activation.

Brohl AS et al.

Scientific Reports, 2017

29118384 (PubMed )
Supplement: 41598_2017_15183_MOESM1_ESM.pdf

Mutation spectrum of TP53 gene predicts clinicopathological features and survival of gastric cancer.

Tahara T et al.

Oncotarget, 2016

27323394 (PubMed )
Supplement: oncotarget-07-42252-s002.xlsx › all_non_silent_mutations_

Analysis of FOXO1 mutations in diffuse large B-cell lymphoma.

Trinh DL et al.

Blood, 2013

The Czech National Diamond-Blackfan Anemia Registry: clinical data and ribosomal protein mutations update.

Pospisilova D et al.

Blood Cells, Molecules & Diseases, 2012

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."